Weekly cisplatin and nab-paclitaxel neoadjuvant chemoradiotherapy increases pathological complete response in locally advanced esophageal squamous cell carcinoma: A real-world study [0.03%]
周予顺铂和白蛋白结合型紫杉醇新辅助化学放射治疗可增加局晚期食管鳞癌的病理完全缓解：一项真实世界研究
Li Li,Xuquan Jing,Jiling Niu et al.
Li Li et al.
Although neoadjuvant chemoradiotherapy (nCRT) is the standard treatment regimen for patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC), no consensus exists regarding the optimal chemotherapy regimen. The present stu...
Breaking senescence restriction: MAFK-AREG axis promotes NSCLC cells to resist doxorubicin [0.03%]
突破衰老限制：MAFK-AREG轴促进非小细胞肺癌细胞抵抗多柔比星作用
Ningning Fan,Guanying Liang,Jiayue Shao et al.
Ningning Fan et al.
Musculoaponeurotic fibrosarcoma oncogene homolog K (MAFK) and amphiregulin (AREG) promote non-small cell lung cancer (NSCLC) progression. However, whether MAFK regulates AREG to mediate the escape of NSCLC cells from doxorubicin (DOX)-induc...
Gastrointestinal cancer with indeterminate 18F-FDG PET/CT findings: Diagnostic efficacy analysis of 68Ga-FAPI-04 PET/MRI [0.03%]
胃肠道癌症的18F-FDG PET/CT检查结果不确定时，68Ga-FAPI-04 PET/MRI诊断效能分析
Jingxuan Miao,Yifei Xu,Feng Qiao et al.
Jingxuan Miao et al.
The present prospective study aimed to investigate whether gallium-68-labeled fibroblast activation protein inhibitor-04 (68Ga-FAPI-04) positron emission tomography (PET)/magnetic resonance imaging (MRI) could provide notably increased diag...
PD-1 inhibitors combined with tyrosine kinase inhibitor-associated hypothyroidism is a predictive factor for antitumor effectiveness in male patients with hepatocellular carcinoma [0.03%]
PD-1抑制剂与酪氨酸激酶诱导的甲状腺功能减退可作为男性肝细胞癌患者抗肿瘤效力的预测因素
Bailu Cao,Min Ai,Ping Huang et al.
Bailu Cao et al.
Tyrosine kinase inhibitors (TKIs) and programmed cell death protein-1 (PD-1) inhibitors are well-established first-line systemic therapies for hepatocellular carcinoma (HCC), with hypothyroidism as a prominent immune-related adverse event. ...
A novel prognostic biomarker combining TP53 loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy [0.03%]
化疗治疗的肺鳞状细胞癌中结合TP53功能丧失和九种基因的不同组合拷贝数放大作为新型预后生物标志物的研究
Yuli Li,Ting Hou,Hongjie Liu et al.
Yuli Li et al.
Lung squamous cell carcinoma (LUSC) is a prevalent subtype of lung cancer, which is primarily characterized by poor prognosis due to the lack of targeted therapies, while a large proportion of patients show limited response to chemotherapy....
Erratum: [Corrigendum] EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells in vitro [0.03%]
【更正】EGFR和ERK活化使黄酮类化合物山柰酚的抑癌活性失活：体外人宫颈癌细胞模型中的研究
Xin Chen,Pengli Xu,Huijun Zhang et al.
Xin Chen et al.
[This corrects the article DOI: 10.3892/ol.2021.13015.]. Copyright: © Chen et al.
Published Erratum
Oncology letters. 2026 May 8;32(1):287. DOI:10.3892/ol.2026.15642 2026
Meta-analysis of efficacy comparisons between standard- and low-dose Bacillus Calmette-Guerin vaccines in managing non-muscular invasive bladder cancer [0.03%]
卡介苗标准剂量与低剂量治疗非肌层浸润性膀胱癌的疗效比较meta分析
Xiaoxi Liu,Yige Bao
Xiaoxi Liu
Intravesical Bacillus Calmette-Guerin (BCG) is the first-line therapy for non-muscle-invasive bladder cancer (NMIBC), yet its clinical use is limited by high adverse event rates and a global supply shortage. A comparison was conducted to ex...
Cumulative evidence for associations between matrix metalloproteinase-1, -3 and -8 variants and cancer risk [0.03%]
基质金属蛋白酶-1、-3和-8的基因多态性与癌症风险的相关性研究累积证据
Suqin Xu,Xianping Liu,Chenglu Huang
Suqin Xu
Matrix metalloproteinase (MMP) gene polymorphisms have been implicated in cancer susceptibility; however, the results from previous studies have been inconsistent across populations and tumor types. The present study aimed to systematically...
Immunotherapy retreatment with serplulimab vs. chemotherapy in extensive-stage advanced small cell lung cancer [0.03%]
用于广泛期小细胞肺癌免疫治疗失败后挽救性治疗的赛普利单抗与化疗对比研究
Xinhang Gu,Xue Wu,Jiaxiao Geng et al.
Xinhang Gu et al.
The present study compared the effectiveness and safety of immunotherapy retreatment with serplulimab vs. chemotherapy in extensive-stage small cell lung cancer (ES-SCLC). This real-world retrospective cohort study included patients with ES...